Association of Genomic Alterations with the Presence of Serum Monoclonal Proteins in Chronic Lymphocytic Leukemia
- PMID: 39594588
- PMCID: PMC11592641
- DOI: 10.3390/cells13221839
Association of Genomic Alterations with the Presence of Serum Monoclonal Proteins in Chronic Lymphocytic Leukemia
Abstract
The presence of a monoclonal protein detected by serum immunofixation electrophoresis (sIFE) has been reported as an adverse prognostic factor in chronic lymphocytic leukemia (CLL). However, the genetic underpinning of this finding has not been studied. We retrospectively studied 97 CLL patients with simultaneous information on sIFE and genetic alterations detected by next-generation sequencing. sIFE was positive in 49 patients. The most common isotypes were IgG κ (27%) and bi/triclonal (25%). A +sIFE was associated with a higher number of mutated genes [median 2 (range 0-3) vs. 0 (range 0-2), p = 0.006], and a higher frequency of unmutated IGHV status (60 vs. 29%, p = 0.004). An IgM monoclonal protein was associated with TP53 mutations (36% in IgM +sIFE vs. 12% in non-IgM +sIFE or -sIFE, p = 0.04), and bi/triclonal proteins with NOTCH1 mutations (33% in bi/triclonal vs. 9% in monoclonal +sIFE or -sIFE, p = 0.04). These data suggest an association between a +sIFE and a higher mutational burden, and some monoclonal isotypes with specific mutations.
Keywords: chronic lymphocytic leukemia; next-generation sequencing; serum monoclonal protein.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
References
-
- Alberts B., Johnson A., Lewis J., Raff M., Roberts K., Walter P. Molecular Biology of the Cell. 4th ed. Garland Science; New York, NY, USA: 2002. [(accessed on 3 March 2024)]. B Cells and Antibodies. Available online: https://www.ncbi.nlm.nih.gov/books/NBK21054/
-
- Wahed A., Quesada A., Dasgupta A. Hematology and Coagulation. Elsevier; Amsterdam, The Netherlands: 2020. Monoclonal Gammopathies and Their Detection; pp. 113–126.
Publication types
MeSH terms
Grants and funding
- Contratos de Recerca Clínic - La Pedrera 2023/Fundació Catalunya La Pedrera and Hospital Clínic de Barcelona
- PID2021-123165OB-I00/Spanish Ministry of Science and Innovation
- CB16/12/00334/Consorcio Centro de Investigación Biomédica en Red
- CB16/12/00225/Consorcio Centro de Investigación Biomédica en Red
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
